Improving Healthcare Through Disruptive Innovation
Medical Excellence Capital (MEC) is an early stage life sciences fund that combines a unique global network of leading physician scientists with a team of experienced investors, company builders, and operators.
Focusing on the Future of Precision Health
At MEC, we believe the post Covid-19 era will lead to a golden age in innovation within the life sciences space.
MEC invests in company creation, seed and Series A opportunities where technology and novel approaches are transformational including, but not limited to:
- Gene Therapy
- Cell Therapy
- Synthetic Biology
- Regenerative Medicine
- AI-Enabled Drug Discovery & Development
Tapping into a Global Network of Opportunity
MEC leverages Medical Excellence Group’s (MedEx) proprietary physician and academic medical center platform to curate a unique deal flow of emerging, breakthrough technologies thoroughly vetted by our own team of industry experts.
Leveraging Unparalleled Industry Expertise
We created the MEC Council, a carefully-curated subset of our 1,100+ physician/scientist panel to create a unique competitive edge. The Council enables us to get smart very quickly on a complex business opportunity theme, evaluate an investment hypothesis, or to accelerate the development of an existing MEC portfolio company.
MEC Council members include acclaimed subject matter experts across all areas of healthcare and biotech, from drug discovery researchers to experts in clinical development and regulatory requirements.
Purpose Built Team
MEC is comprised of seasoned investors and health venture operators, each with a track record of success across multiple sectors in healthcare investment and operating environments.
John Prufeta, MBAFounder, CEO & General Partner
Eric Heil, MBAManaging Partner
Kim Kamdar, PhDManaging Partner
Brian Halak, PhDManaging Partner
Joni Mancini, CPAManaging Partner & COO/CFO
Olga PrufetaMEC LP Liaison;
Medical Excellence Group
John Hornbostel, Esq.Counsel
Kevin Emesiani, PharmD, MBAAssociate
Engaging with World-Class Scientific Advisors
Acclaimed innovators themselves in the fields of regenerative medicine, gene therapy, and mitochondrial medicine, the MEC scientific advisory board brings critical perspective to evaluating new opportunities and providing added value to portfolio companies.
MB ChB, PhD
2019 Nobel Laureate
CHOP | UPenn
Learn More About MEC
For more information on Medical Excellence Capital and our investment strategy, please refer to the resources below or contact us.